TSPO and Huntington disease: Vainshtein et al. and Veenman et al. showed an ameliorating effect of the TSPO ligand 2-Cl-MGV-1, which was vastly superior to PK 11195 and MGV-1 in a transgenic mouse model for HD [28,85].